1.7 ML phentolamine mesylate 0.235 MG/ML Cartridge [OraVerse]
RxNorm concept 1361021, branded drug (sbd). Prescribable name: OraVerse 0.4 MG in 1.7 ML Cartridge.
- RxCUI
- 1361021
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1361021 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
OraVerse 0.235 MG/ML per 1.7 ML Cartridge; OraVerse 0.4 MG per 1.7 ML Cartridge
Related concepts
- phentolamine mesylate 0.235 MG/ML (SCDC, consists of)
- phentolamine mesylate 0.235 MG/ML [OraVerse] (SBDC, consists of)
- Cartridge (DF, has dose form)
- OraVerse (BN, has ingredient)
- 1.7 ML phentolamine mesylate 0.235 MG/ML Cartridge (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1361021 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1361021 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1361021. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.